Committed to promoting healthy outcomes

About Us

Quadrant Biosciences Inc. is a collaborative effort led by company founder Richard Uhlig. Our management team has been carefully balanced to facilitate the ongoing development, testing and distribution of our products, and includes expertise in engineering, FDA regulatory compliance, production, marketing and sales. Our advisory board comprises highly regarded medical experts and data scientists.

Executive Team

Richard Uhlig

Founder and Chief Executive Officer

With more than 25 years of business experience focused on the design and development of innovative products across various industries, Richard’s management capabilities range from ownership of regional retail businesses to the start-up and management of major corporate divisions with domestic and international product sourcing and sales experience. Previously, he was the Chairman and Chief Executive Officer of Morgan Stanley Bank, the principal banking subsidiary of Morgan Stanley, and was the Chief Investment Officer at Merrill Lynch Bank. He held other significant posts in the financial industry and served as an Executive in Residence at Cornell University’s Johnson Graduate School of Management. Richard is a graduate of Cornell University.

Cynthia Dowd Greene

Chief Operating Officer

Cynthia has a track record of success in the healthcare industry, working with start-up companies and large multinational corporations. She worked for Bristol Myers Squibb for many years, where she was a member of the executive teams of the U.S. Oncology and Immunology Group and Technical Operations. Upon leaving Bristol Myers Squibb, Cynthia went on to help build several successful small companies. This path led her to join the Academic Medical Health Center at SUNY Upstate Medical University, where she worked with medical researchers and local start-up companies in the healthcare field. Cynthia received a BS in Chemical Engineering from Clarkson University and an MBA from the University of Connecticut.

Chrys Chrysanthou

Chief Financial Officer

Chrys is a well-rounded, entrepreneurial and growth focused Leader with a proven track record of success delivering results in diverse disciplines during a 20 plus year career. Prior to joining Quadrant Biosciences, Chrys spent over 9 years with Zimmer Biomet including roles as the Global Head of Finance for Zimmer Biomet’s Spine, Dental, and CMF & Thoracic divisions, Senior Director of Finance, Operations and Logistics for Canada and Director of Finance for Canada and Latin America. Prior to Zimmer Biomet, Chrys worked in various other senior positions including Director of Finance at Stryker Canada and General Manager at Nadiscorp Logistics Group. Chrys holds an honors Bachelor of Business Administration Degree from Wilfrid Laurier University in Waterloo, Ontario, Canada and is a Chartered Professional Accountant.

Randall L. Carpenter, MD

Executive Vice President - Clinical Development

Dr. Carpenter has over 30 years experience in primary care, academic medicine, basic science and clinical research, and pharmaceutical drug development. His experience in the pharmaceutical and biotechnology industries include Co-Founder, President and CEO of Seaside Therapeutics, President and CEO of Sention, VP of Clinical Research & Development and Regulatory Affairs at Adolor Corporation and member of Astra Pain Control’s Global Therapeutic Area Team. While in industry, Dr. Carpenter led translational medicine teams responsible for 8 successful IND submissions and dozens of GCP-compliant clinical trials. Prior to joining industry, he held academic faculty appointments at Virginia Mason Medical Center, the University of Washington and Wake Forest University where he specialized in anesthesiology, pain management and translational medicine.

David MacLean

Executive Vice President - Marketing

David has more than 25 years of business, research and legal experience. He recently produced two award-winning feature and documentary films and founded an MMA website and clothing company. David was the co-owner of a mixed-martial arts promotion company and co-owner and manager of a medical-device sales distribution company. Previously, he was a litigator at the firms of LeBoeuf, Lamb, Lieby & MacRae, and Nixon Hargrave Devans & Doyle. Earlier, he was a research biologist for the Cornell University Lab of Ornithology. David earned a BS from Cornell University and a JD from the University of Buffalo Law School, where he was a member of the Law Review.

Scott Giambalvo

Executive Vice President - Global Sales

Scott has over 25 years experience in the medical device and health industry working with both multi-national corporations and startup companies. For the last ten years, he has managed Scott Alan Enterprises, a boutique firm building management organizations, creating driven sales teams, and implementing strategic positioning and marketing campaigns to fill needed skill sets for medical device and health IT companies. Previously, Scott honed his leadership skills and industry knowledge for fourteen years at Stryker Corporation and later at OraMetrix. Scott earned an MBA in Entrepreneurship & Marketing from Carnegie Mellon University and bachelor's degrees in Economics and Chemistry from Cornell University.

James Croke

General Counsel

Jim was previously a structured finance/banking partner at Chapman & Cutler, Orrick, Herrington, Cadwalader and Hunton & Williams. Throughout his career, he served as counsel to underwriters and issuers in U.S. and global public offerings and private placements. Jim has been a member of the board of directors of the American Securitization Forum and a faculty member of the Practicing Law Institute. He has written and lectured on a variety of topics regarding legal and regulatory issues and annually served as a guest lecturer regarding U.S. corporate and finance law at The Universidad Panamericana in Guadalajara, Mexico. Jim practiced U.S. law in London from 1999 - 2004, as the head of Cadwalader, Wickersham & Taft LLP's London capital markets department. Jim earned his undergraduate degree in Mathematics from the University of Kentucky and his J.D. degree from the University of Notre Dame Law School.

Chris Horacek

Deputy General Counsel

Chris has more than 20 years of experience as corporate counsel on matters including transactions, business development, intellectual property, and regulatory compliance. He served as Deputy General Counsel and Compliance Officer for Welch Allyn, Inc. for more than 10 years, and in that capacity managed the attorneys in the legal department who worked in the areas of transactions, intellectual property, and compliance, and also served on the executive team that managed the Quality and Regulatory departments. Chris is an adjunct professor at the Syracuse College Of Law, and teaches a section of the class on technology commercialization. He received a BS in Medicine from the University of Nebraska, and a JD, with distinction, from the University of Nebraska College Of Law.

Alexander Rajan, PhD

Vice President- Clinical Research

Dr. Rajan has a varied career in biomedical sciences, from basic and translational research, life science and computational biology education and outreach, emergency medicine, and biotech startups. He began his research career investigating autism diagnostics, and has managed, led, and consulted on research projects in vision, somatosensation, proprioception, and motor systems involving biomechanics, neuroanatomy, electrophysiology, and stimulation. His funding sources have included the NSF, NIH, and DARPA. His startup work has been in sales and marketing and in research and development. Dr. Rajan earned a BS in biopsychology from the University of California, Davis and a PhD in computational neuroscience from the University of Chicago.

Andrew Brindle

Vice President - Engineering

Andrew brings a strong background in hardware design and development to the Motion Intelligence team. His career has included over 12 years in the defense industry working on sophisticated radar systems such as the DARPA FORESTER, the Army’s AN/TPQ-49, and radar antennas for drone helicopters. Andrew developed and holds patents on new technologies involving efficient heat transfer, and has a strong background in algorithm development having created algorithms for deep-sea underwater sensors and sports performance technologies. More recently, he has run his own engineering consulting business with a focus on commercial manufacturing and medical devices. Andrew received a B.S. in Mechanical Engineering with a minor in Mathematics from Clarkson University.

Benjamin Perry

Vice President - Technology

Ben’s career in technology encompasses a wide breadth of expertise in software development, including enterprise web applications, cloud computing and human computer interaction. During his experience as both a senior developer and project manager, he led projects involving crowdsourced metadata curation, inventory control tools, and identity management solutions. Before coming to Quadrant Biosciences, Ben developed software for the federal statistical system and public opinion domain. He received his Master’s degree in Information Science from Cornell University.

Bryan Greene

Vice President - Regulatory Compliance and Supply Chain Management

Bryan brings to the Motion Intelligence team more than 10 years of experience in medical device operations, manufacturing, validation and new-product introduction at both large multinational and start-up corporations. He has a proven track record of successfully introducing Class I, II and III products at Life Technologies (Thermo Fisher Scientific), Pall Corporation and ImClone System (Eli Lilly). Most recently, Bryan was the manufacturing and operations leader during establishment and implementation of an FDA 21CFR820 compliant system at Rheonix, a medical device start-up. He received a BS in Chemical Engineering from Clarkson University.

Jeremy Williams

Vice President - Technology

Jeremy has developed software solutions in the financial sector, the GIS industry and in support of large-scale social science research. He has held leadership roles in a number of successful projects, both academically and commercially. He was responsible for designing a citizen science project funded by the NEH and used in secondary schools and colleges across the country. He has also led the development of restricted access Census Bureau metadata repository software funded by the NSF. His experience spans complex systems integration, mapping software used by state and municipal governments to manage geo-spatial data, and applications for research data analysis and dissemination. During Jeremy’s career, he has developed expertise in a variety of technologies, with a focus on information system architecture. He graduated with a Master’s degree in Information Science from Cornell University.

David Huffman

David Huffman

Director of Mobile Architecture

Dave’s career has spanned the spectrum of software development including enterprise, web, and mobile applications. While a senior developer, he led projects involving cloud computing, scalability, and internationalization. Prior to joining Quadrant Biosciences, Dave built iOS and Android applications supporting citizen science projects used by over 100,000 people globally in over 20 languages. He received a Bachelor’s degree in Computer Science from the Rochester Institute of Technology.

Kayla Wagner

Director of Clinical Operations

Kayla has spent her career dedicated to working with children and adolescents with neurodevelopmental disorders in both clinical and research settings. In her clinical work she provided diagnostic and counseling services to children and adolescents with psychiatric disorders. Her research spans many areas of child psychopathology, including autism spectrum disorder, ADHD and 22q11.2 Deletion Syndrome. More specifically, she has investigated the comorbidity between autism and ADHD, genetic and familial relationships within RDOC constructs, and factors related to poor social outcomes (e.g., relationship development/maintenance with friends, family, romantic partners) in children, adolescents, and adults with neurodevelopmental disorders. Kayla earned a BS in neuroscience and psychology and an MS in Clinical Psychology at Syracuse University.

Medical and Scientific Collaborators

Anthony Petraglia, MD

Chief Medical Officer, Motion Intelligence LLC

Dr. Petraglia is an attending Neurosurgeon at Rochester Regional Health in Rochester, NY, Dr. Petraglia specializes in all aspects of spine and brain surgery. He has extensive subspecialty experience in sports-related neurological injuries, co-authoring with Dr. Julian Bailes the Handbook of Neurological Sports Injuries, a well-regarded treatise on concussion in sports. Dr. Petraglia is the Executive Director of the Rochester Regional Concussion Center.

Steven Hicks, MD, PhD

Dr. Hicks is an Assistant Professor of Academic General Pediatrics at Pennsylvania State College of Medicine in Hershey, PA. He is a physician scientist who studies the influence of genetics and the environment on pediatric diseases involving growth and neurodevelopment. More specifically, Dr. Hicks is interested in how peripheral epigenetic factors such as microRNA may be utilized to predict patient oriented outcomes in pediatric disorders of neurodevelopment (e.g. autism, concussion) and growth (e.g. annorexia nervosa, obesity). His research has been recently published in JAMA Pediatrics and the Journal of Neurotrauma.

Frank Middleton, PhD

Dr. Frank Middleton is an Associate Professor in the Department of Neuroscience & Physiology, Department of Psychiatry & Behavioral Sciences and the Department of Biochemistry & Molecular Biology at SUNY Upstate Medical University. He is the founder and director of the SUNY Molecular Analysis Core facility, which specializes in next-generation sequencing analysis, and has published more than 120 peer-reviewed articles and a dozen book chapters. He is a chief section editor for Behavioral Brain Functions and Frontiers in Genetics.

Christopher Neville, PT, PhD

Dr. Neville is the associate Professor of Clinical Health Practices at SUNY Upstate Medical University, Dr. Neville has a clinical background as a physical therapist, treating patients with mild traumatic brain injury and various orthopedic conditions before completing his PhD in Health Practice Research with a Biometrics focus. He has more than 50 peer-reviewed journal and conference publications, as well as a history of federal grant funding.

Brian Rieger, PhD

Dr. Rieger is the director of the Concussion Center at SUNY Upstate Medical University and a Clinical Assistant Professor of Rehabilitation Psychology, Dr. Rieger specializes in concussion management and sports-related concussion.

Claudine Ward, MD

Dr. Ward is an assistant Professor of Physical Medicine and Rehabilitation at SUNY Upstate Medical University, Dr. Ward is a clinician who specializes in acquired brain injury, including concussion and management of spasticity.

Data Management Collaborators

William C. Block, PhD

Dr. Block is the director of the Cornell Institute for Social and Economic Research (CISER)—home of the world’s most advanced environments for research with restricted social, economic and health data—Dr. Block has Special Sworn Status for working with restricted federal statistical data. Prior to Cornell, he spent nearly 20 years at the Minnesota Population Center.

Board of Directors

Ira Fedder, MD

Dr. Fedder is a fellowship trained orthopedic spine surgeon practicing at the University of Maryland, St. Joseph Medical Center in Towson, Maryland. Dr Fedder is Board Certified by the ABOS as well as the ABSS and an active member of a number of professional organizations. Dr Fedder has participated in a number of clinical trials, has published widely in both the orthopedic and pharmacology literature, and has been an active lecturer speaking about the current and future use of stem cells and other biologics in orthopedics. Dr Fedder received his Doctor of Pharmacy degree from the U of Maryland School of Pharmacy in 1979. Subsequently, Dr. Fedder completed a fellowship in Clinical Pharmacology at Thomas Jefferson University School of Medicine. After teaching at Northeastern University College of Pharmacy and the Veterans Administration in Boston, Dr. Fedder then returned to the University of Maryland where he graduated from the School of Medicine in 1986. After completing his residency in Orthopedic Surgery at the University of Maryland he completed a fellowship at St Joseph Medical Center in Towson. He has practiced as an orthopedic spine surgeon since 1992.

Andrew Rock

Mr. Rock earned a reputation as a successful serial entrepreneur in the global medical technology industry. He is co-founder of K2M Group, a medical device developer based in Leesburg, Va., which became listed as a publicly traded company on NASDAQ on May 5, 2014. While at K2M, Mr. Rock developed over 17 utility and method patents for the treatment of complex spine pathologies including scoliosis, tumor and trauma, as well as for minimally invasive implants. Before his involvement in K2M, Mr. Rock was a member of the executive management team at American Osteomedix, where he co-developed a minimally invasive approach to access and treat osteoporotic compression fractures and tumors in the thoracic spine. From 1993 to 2003, he was Chairman and CEO of Rock Surgical Associates, Inc., a distributor of Orthopedic and Neurosurgical Products in the Mid-Atlantic region. Currently, Mr. Rock is the founder and managing partner of Neuro Spine Ventures LLC, an 82-member global angel investor group. Mr. Rock is also Co-Founder and Executive Director of DP Enterprises Group Inc., which provides product development and global marketing services for med-tech companies. Mr. Rock also serves on the Board of Directors for several corporations, including Quadrant Biosciences, Inc. which focuses on brain health and epigenetics diagnostics; Minneapolis-based St Teresa Medical Inc., a developer of nanotechnology-based hemostatic and dural sealants; Connecticut based Woven Orthopedics, LLC which specializes in fixation and osteoporotic and osteopenic. He is on the board of advisors for Indianapolis-based Recovery Force, LLC, and a pioneer in wearable technology for the medical, sports and defense industry sectors Mr. Rock graduated from Linsly and West Virginia University.

Mary Ann Tyszko

Ms. Tyszko has over 30 years of experience in program planning, execution, and management. She served as Chief Executive Officer and President of SRCTec Inc. from its inception until August 2010. Prior to that, she served as an Executive Vice President, Operations for SRC, responsible for the day-to-day management and financial results of SRC's four business centers. Ms. Tyszko is Chair of the Greater Syracuse Chamber of Commerce Board of Directors, and a Member of Le Moyne College Management Division Advisory Board. She is a National Director of the Association of Old Crows (AOC) and a Member of the Armed Forces Communications and Electronics Association (AFCEA), the Association of the United States Army (AUSA), the United States Field Artillery Association (USFAA), and the National Association of Corporate Directors (NACD). Ms Tyszko also has been Corporate Chair of Go Red for Women, American Heart Association, as well as a Board Member of Manufacturers Association of Central New York (MACNY). She received her MBA and MS in Computer Science from Syracuse University and a BS in Biology from Le Moyne College.

Richard Uhlig

Mr. Uhlig is the Founder and CEO of Quadrant Biosciences Inc. He has more than 29 years of business experience with a focus on leading start-up and high-growth businesses. Previously, Mr. Uhlig served as the Chairman and Chief Executive Officer of Morgan Stanley Bank, the principal banking subsidiary of Morgan Stanley, where he engineered the growth of the bank from $8 billion to $35 billion in less than two years. Prior to Morgan Stanley, Mr. Uhlig was the Chief Investment Officer for Merrill Lynch Bank USA, building and managing a $65 billion proprietary trading portfolio. Prior to Merrill Lynch, Mr. Uhlig served as a Managing Director at Deutsche Bank AG where he was a bond trader and the Co-Head of the Mortgage-Backed Securities Department for the Americas and Asia. Earlier in his career, Mr. Uhlig was an investment banker at Lehman Brothers and Goldman, Sachs & Co. Mr. Uhlig is a graduate of Cornell University and served as an Executive in Residence at Cornell while lecturing at the Johnson Graduate School of Management.

Wade West

Mr. West brings over 39 years of entrepreneurial business experience in leadership, sales, marketing and business development. He is the founder and President of General Orthopedics, an orthopedic and neurosurgery focused medical sales and distribution company based in San Antonio, Texas. Mr. West began his career with Minolta Reprographic Systems, eventually becoming a national accounts executive. He then transitioned into the orthopedic market, taking a sales position with Biomet where he was recognized as the top sales representative for four consecutive years. In 1992, Mr. West became the first Biomet Spine distributor in the United States, at which time he founded General Orthopedics. A driven entrepreneur, Wade has provided consulting services to a number of startup and growing companies in the orthopedic and medical device industry. He is actively involved in several charitable organizations including Wish For Our Heroes.

Richard Bongo

Mr. Bongo has over 30 years of finance experience while working at many major Wall Street firms. He is currently a Managing Director at BNP Paribas, one of Europe's largest banks, and has also worked at such firms as Lehman Brothers, Credit Suisse, Merrill Lynch and Bank of America. Mr. Bongo's experience spans several different disciplines in structured finance including structuring, trading and sales at the institutional level, where he helped to usher in several cutting edge financial investment products such as Collateralized Mortgage Obligations and Commercial Mortgage Backed Securities and Collateralized Loan Obligations. Mr. Bongo began his career at Coopers & Lybrand (Pricewaterhouse Coopers) where he received his CPA. He holds degrees in both Computer Information Systems and Accounting from Kings College where he was also President of his class and Student Government Chairperson.

Cynthia Dowd-Greene

Cynthia has a track record of success in the healthcare industry, working with start-up companies and large multinational corporations. She worked for Bristol Myers Squibb for many years, where she was a member of the executive teams of the U.S. Oncology and Immunology Group and Technical Operations. Upon leaving Bristol Myers Squibb, Cynthia went on to help build several successful small companies. This path led her to join the Academic Medical Health Center at SUNY Upstate Medical University, where she worked with medical researchers and local start-up companies in the healthcare field. Cynthia received a BS in Chemical Engineering from Clarkson University and an MBA from the University of Connecticut.

We are located in the Institute for Human Performance at SUNY Upstate Medical University.